IGNITE researchers collaborate to improve patient outcomes through genomics

A collaborative IGNITE Network study shows that a quick, precise genetic test can significantly reduce the risk of cardiovascular events by helping to identify more effective medication for some heart patients. University of Florida researcher Larisa Cavallari, Pharm.D., presented these findings at the American Heart Association Scientific Sessions on Nov. 15, 2016.

0 comments

IGNITE Network highlighted in the Journal of the American Medical Association

Journal of the American Medical Association – Duke University’s Dr. Geoffrey Ginsburg and University of Florida’s Dr. Julie Johnson discuss the value of and challenges facing the use of pharmacogenomics to improve patient care.

0 comments

The Gainesville Sun spotlights the history and accomplishments of the UF Health Personalized Medicine Program

The Gainesville Sun – The University of Florida’s Dr. Julie Johnson and Dr. Larisa Cavallari discuss the trail the IGNITE Network’s UF Health Personalized Medicine Program has blazed in the field of precision medicine since its founding.

0 comments

Duke University study uncovers clues as to how aspirin may help prevent colon cancer

The Duke Chronicle – Dr. Geoffrey Ginsburg of the Duke Center for Applied Genomics and Precision Medicine explains how aspirin’s mechanism of action may help prevent not just cardiovascular disease, but also colon cancer.

0 comments

IGNITE Network’s Mia Levy participates in NCI summit on health IT policy

The American Journal of Managed Care – Dr. Mia Levy of the Vanderbilt Ingram Cancer Center describes opportunities for the successful dissemination and use of actionable health data for researchers and clinicians alike.

0 comments

Mount Sinai obesity research featured in The New York Times

The New York Times – IGNITE Network’s Dr. Carol Horowitz works to reduce disparities in obesity and diabetes in underserved areas of New York City.

0 comments

University of Florida researcher’s heart beats for pharmacogenomics

Genetic Engineering & Biotechnology News – Dr. Julie Johnson of the UF Health Personalized Medicine Program illuminates how current and future advancements in pharmacogenomic research can lead to additional improvements in the treatment of cardiovascular disease.

0 comments

UF Health Personalized Medicine Program featured in GATORx

The UF College of Pharmacy and UF Health Personalized Medicine Program are studying the enzyme CYP2D6 to help doctors identify the most effective pain medications for patients like Jeff Cruse, a grandfather whose severe back pain was poorly controlled for years before enrolling in the study.

0 comments

Vanderbilt University’s Mia Levy named Komen Scholar

Breast Cancer News – As one of the prestigious Komen Scholars, Dr. Mia Levy will help guide research and advocacy conducted by the Susan G. Komen Foundation.

0 comments

American Association of Colleges of Pharmacy recognizes outstanding work of University of Florida’s Julie Johnson

AACP News Release – Dr. Julie Johnson received the 2016 Volwiler Research Achievement Award in recognition of sustained excellence in research and scientific contributions.

0 comments

Inaugural UF Precision Medicine Conference: A ‘pharmacogenomics army of champions’

Pharmacy Times – The University of Florida (UF) College of Pharmacy and the UF Health Personalized Medicine Program (PMP) recently hosted a Precision Medicine Conference and certificate training program for pharmacists in Orlando, Florida.

0 comments

Duke University study emphasizes importance of family history in patient care

Duke Medicine News and Communications – Lead author Lori Orlando, M.D., showcases a Duke University study published in the Journal Genetics in Medicine that exposes both the expected and unexpected benefits of using MeTree, a web-based family health history tool.

0 comments

University of Maryland diabetes research highlighted in Genome

Genome – Toni Pollin and her colleagues at the University of Maryland’s Program in Personalized and Genomic Medicine have recently implemented a survey for people diagnosed with diabetes that is designed to find and diagnose people with other forms of diabetes, such as MODY.

0 comments

NIH researchers identify genomic signature shared by five types of cancer

National Human Genome Research Institute – Researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer. They also found evidence that this methylation signature may be present in many more types of cancer.

0 comments

NIH’s IGNITE and eMERGE Networks hold joint meeting in Nashville, TN

IGNITE Network – In the first joint network meeting, investigators discuss findings and strategies for advancing genomic medicine

0 comments

University of Florida hosts inaugural Precision Medicine Conference in Orlando, FL

University of Florida – The expanding role of pharmacogenomics in clinical medicine and education was the focus of the inaugural Precision Medicine Conference

0 comments

IGNITE research in the spotlight in Florida news story

Business Report of Central North Florida – In the weeks and months after a patient gets a heart stent, blood clots can pose a major threat to recovery. Now, University of Florida Health researchers have found that a quick genetic test can tell doctors early on whether a crucial anti-clotting drug will work

0 comments

IGNITE Network’s Josh Denny appointed to team of precision medicine experts for Obama

National Institutes of Health – A newly created team of experts in precision medicine and large clinical research studies will seek public input from the large and diverse stakeholder community interested in the development of the President’s Precision Medicine Initiative and articulate the vision for building the national participant group for the Initiative.

0 comments

IGNITE newsletter features SPARK Toolbox, network updates

The IGNITE Network’s quarterly newsletter provides timely information on developments within the network with a specific focus on genomic implementation tools available for clinicians, researchers, health educators and patients.

0 comments
* indicates required